Skip to content
AI IntelligenceFeb 13, 2026Secondary Market
Article

VVB (维眸生物)

Biotech company Weimou Biotech (维眸生物) has submitted an initial public offering (IPO) application to the Hong Kong Stock Exchange (HKEX). The Zhejiang-based company has appointed China International Capital Corporation (CICC) as the sole sponsor for its planned listing.

Data Cube AI EditorialSource: 36Kr
01

Source Brief

Biotech company Weimou Biotech (维眸生物) has submitted an initial public offering (IPO) application to the Hong Kong Stock Exchange (HKEX). The Zhejiang-based company has appointed China International Capital Corporation (CICC) as the sole sponsor for its planned listing.